Max Planck Institute of Molecular Cell Biology and Genetics

What Max Planck Institute of Molecular Cell Biology and Genetics does

Max Planck Institute of Molecular Cell Biology and Genetics (MPI-CBG) is a non-profit basic research institute founded around 2000 in Dresden, Germany, and a member institute of the Max Planck Society (Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.). The institute employs approximately 500 scientists drawn from more than 50 countries and operates four interconnected research programs: Molecular and Cellular Systems, Physics of Living Systems, Mathematics and Artificial Intelligence, and Organoids and Organisms. Its research question — how cells form tissues — is pursued through reconstituted in vitro systems, classical animal models, three-dimensional organoids, and theoretical/computational frameworks that combine biology, physics, mathematics, and computer science.

MPI-CBG's core technical platform includes novel imaging methods (notably a chemical-labeling strategy for visualizing individual lipids in cells via standard fluorescence microscopy), high-resolution biological mass spectrometry (shotgun lipidomics, label-free quantitative proteomics, and absolute molar protein quantification via MS Western and FastCAT workflows), and mathematical methods such as topological data analysis, multiscale topology for spatial transcriptomics, and topological approximate Bayesian computation (TABC) for parameter inference. AI-assisted image segmentation and machine learning are applied to biological data across multiple modalities (image, structured data, text). The institute also operates core facilities providing analytical services and runs PhD and postdoctoral training programs.

The institute does not sell commercial products or services; it is funded primarily through institutional core funding from the Max Planck Society (sourced from German federal and state governments) and competitive research grants from agencies such as the European Research Council, DFG, and BMBF. Its customer base, in the conventional sense, is the global scientific research community; research findings are disseminated via peer-reviewed open-access publications, scientific conferences (including GROW@Dresden co-hosted with TU Dresden), public outreach events (Lange Nacht der Wissenschaften, Girls' Day, Children's Day, Seniorenakademie), and partnerships within the Dresden research alliance (TU Dresden, BIOTEC, CSBD, HZDR, J. Heyrovsky Institute). Strategic positioning centers on pioneering basic science rather than commercialization, with notable external validation including a 2023 Breakthrough Prize in Life Sciences and recent ERC Advanced Grant funding.

Name

Max Planck Institute of Molecular Cell Biology and Genetics

Legal name

Max Planck Society for the Advancement of Science e.V. (Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.)

Website

https://mpi-cbg.de

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Non-profit basic research institute in Dresden, part of the Max Planck Society, employing around 500 scientists from over 50 countries to investigate how cells form tissues through multidisciplinary biology, physics, mathematics, and computer science programs.

Ownership category

akta.pro rank

Product category

Basic Scientific Research Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715), Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731), Laboratory Analytical Instruments (3826), Services-Testing Laboratories (8734)

akta.pro primary industry

In Vitro Model Systems & Organoid Platforms (iPSC/organoids, microphysiological systems) (HLAAAIAJ)

akta.pro secondary industries

Microscopy, Imaging & Flow Cytometry Instruments (HLAGAIAE), AI/ML Platforms for Drug Discovery & Experiment Optimization (HLAGAJAO), Cellomics & High-Content Screening (HCS) Services (HLAGANAD), Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D) (HLAGAJAC), AI/ML-Enabled Biologic Discovery Platforms (computational design, in silico screening) (HLAAAIAE)

Keywords

• Basic research institute
• Molecular cell biology
• Biophysics research
• Biological mass spectrometry
• Computational biology

Headquarters

HQ city

Dresden

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure

Revenue model

1. Public Research Funding: As a Max Planck Institute, MPI-CBG is funded primarily through the Max Planck Society (MPG) which receives core funding from German federal and state governments. Additional funding comes from competitive research grants (e.g., European Research Council, DFG, BMBF).

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

MPI-CBG conducts pioneering basic research in molecular cell biology and genetics, asking how cells form tissues. It combines biology, physics, mathematics, and computer science across four research programs—Molecular and Cellular Systems, Physics of Living Systems, Mathematics and Artificial Intelligence, and Organoids and Organisms—and offers doctoral (PhD) and postdoctoral training, specialized analytical services such as biological mass spectrometry, and public science outreach.

Product overview

The Max Planck Institute of Molecular Cell Biology and Genetics (MPI-CBG) is a non-profit basic research institute, not a commercial product company. The institute operates four interconnected research programs spanning Molecular and Cellular Systems, Physics of Living Systems, Mathematics and Artificial Intelligence, and Organoids and Organisms. These programs work collaboratively, combining experimental approaches with theoretical and computational methods to understand fundamental cellular and developmental biology questions. The institute also provides specialized research technologies including novel lipid imaging methods and biological mass spectrometry services, alongside educational programs (PhD and Postdoc training) and public science outreach activities.

Differentiator

Problem solved

Functional benefit

Products and services

• Biological Mass Spectrometry Services Analytical services including shotgun lipidomics, proteomics, absolute protein quantification, and mass spectrometry imaging for biological systems research, provided to internal and external research users.
• PhD Program Doctoral training program attracting international students for multidisciplinary research training in molecular cell biology, genetics, physics, mathematics, and computer science.
• Postdoc Program Career development program for early-career researchers providing training and mentorship in advanced biological research methodologies.

Quantifiable outcome

• 85-95% of lipid transport between organelle membranes is protein-mediated, 10x faster than vesicle transport
• +1 more outcomes

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability8 records

Feature7 records

Partnerships

Eight partnerships are on record, tiered core and minor.

• TU DresdencoreStrategic or Co-development Partner · 26 March 2026Joint hosting of GROW@Dresden 2026 conference for women in mathematics. Multiple collaborative research programs and shared facilities between MPI-CBG and TU Dresden.
• Biotechnology Center (BIOTEC) at TU DresdencoreStrategic or Co-development PartnerCollaborative research partnership with Alf Honigmann's group for bioimaging development. Joint development of lipid imaging techniques combining MPI-CBG's chemical biology expertise with BIOTEC's imaging capabilities.
• Helmholtz-Zentrum Dresden-Rossendorf (HZDR)coreStrategic or Co-development PartnerCollaboration with Björn Drobot at HZDR for mathematical modeling of lipid transport data. HZDR provided computational analysis supporting the imaging findings.
• J. Heyrovsky Institute of Physical Chemistry, PragueminorStrategic or Co-development PartnerCollaboration with Martin Hof's group for advanced fluorescence spectroscopy to study lipid dynamics.
• Dresden Concept (Research Alliance)coreStrategic or Co-development PartnerMPI-CBG is a member of the Dresden Concept research alliance, a partnership among Dresden's research institutions for collaborative science and shared resources.
• Max Planck Society (MPG)coreStrategic or Co-development PartnerParent organization providing institutional framework, core funding, and administrative support. MPG operates the central web analytics server used by MPI-CBG.
• Center for Systems Biology Dresden (CSBD)coreStrategic or Co-development PartnerJoint research collaboration including hosting of GROW conference and shared computational biology initiatives. Türkü Özlüm Çelik holds joint position at MPI-CBG and CSBD.
• J. Heyrovsky InstituteminorStrategic or Co-development PartnerCollaboration for advanced biophysical measurements supporting lipid transport research.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Francis Crick Institute: Large UK biomedical research institute (~1,500 scientists) with a similar public-research, multidisciplinary model covering cell biology, biophysics, and systems biology — directly comparable in mission and structure.
• HHMI Janelia Research Campus: US private-research institute focused on developing imaging technologies, computational methods, and neurobiology — closely aligned with MPI-CBG's emphasis on novel methods, physics-biology integration, and tool development.
• Salk Institute for Biological Studies: Non-profit basic-research institute with strengths in cell biology, biophysics, and computational biology — similar scale, mission, and operating model.
• Wellcome Trust / CRUK Gurdon Institute: University of Cambridge institute focused on cell biology, developmental biology, and cancer. Closely comparable in mission, scale, and public-research funding model, with a similarly strong publication record.

Broad incumbents

• Broad Institute of MIT and Harvard: Major US biomedical research organization with deep capabilities in cell biology, genomics, and computational biology. Comparable in scale and in the integration of experimental biology with machine learning/AI.
• Institut Pasteur: Large French non-profit research institute with a similar basic-research mission, public funding model, and broad portfolio in cell biology, immunology, and disease research.
• European Molecular Biology Laboratory (EMBL): Europe's flagship life sciences laboratory; MPI-CBG's founding director Anthony Hyman is transitioning to lead EMBL. EMBL operates across multiple sites with broader scope, but shares MPI-CBG's basic-research mission, multidisciplinary approach, and public funding model.

Others

• Other Max Planck Institutes (MPI for Molecular Biomedicine, MPI of Biophysics, MPI for Biology of Ageing): Sister Max Planck Institutes with overlapping mandates in cell biology, biophysics, and molecular biomedicine — same operating model, funding, and accountability structure as MPI-CBG.

Emerging players

• Allen Institute for Cell Science: Non-profit research program focused on cell biology, live-cell imaging, and computational modeling. Highly comparable to MPI-CBG's imaging and AI for cell biology work, though smaller in scope.

Regional players

• RIKEN Center for Biosystems Dynamics Research: Japanese basic-research organization focused on cell and developmental biology with strong imaging and computational components — comparable in mission and methodology, though geographically separate.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/mpicbg
• YouTubeyoutube.com/user/mpicbg
• Facebookfacebook.com/mpicbg
• LinkedInlinkedin.com/company/mpi-cbg
• Instagraminstagram.com/mpicbg

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Max Planck Institute of Molecular Cell Biology and Genetics